Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Buy RARE Stock  Free RARE Stock Alerts

Ultragenyx Pharmaceutical (RARE) SEC Filings & 10K Form

Ultragenyx Pharmaceutical logo
$38.69 -0.67 (-1.70%)
Closing price 04:00 PM Eastern
Extended Trading
$38.70 +0.02 (+0.04%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Ultragenyx Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
03/10/2025
11:53 AM		Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:16 PM		Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:18 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:19 PM		Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:56 PM		Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:02 PM		Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:06 PM		Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:10 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:12 PM		Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
12:58 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:58 PM		Ultragenyx Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
10:42 AM		SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SCHEDULE 13G/A
02/10/2025
9:25 AM		Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
1:05 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:32 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:17 PM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:30 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:44 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:47 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:12 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:42 AM		RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
11/05/2024
3:06 PM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:48 PM		Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
7:15 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:34 PM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
12:03 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:50 AM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:53 AM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:40 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
1:48 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:28 PM		KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
1:07 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:22 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:23 PM		Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:24 PM		NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:25 PM		Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:26 PM		Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:29 PM		Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:22 PM		SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
06/17/2024
5:31 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:11 PM		Ultragenyx Pharmaceutical (Filer)
Form 424B5
06/12/2024
6:47 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:10 PM		Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
4:20 PM		Ultragenyx Pharmaceutical (Filer)
Form 424B5
06/10/2024
6:58 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:20 PM		Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
2:23 PM		Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:35 PM		Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
5:06 PM		Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
7:07 AM		Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RARE) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
Just Revealed: The chip company making AI look primitive
In his just-released video presentation, this renowned market strategist — who's been called "one of the most ...
InvestorPlace | Sponsored